Save up to 90% on Donanemab-AZBT with Coupons, Discount Cards & Patient Assistance Programs

Donanemab-AZBT is available as a 350 mg/20 mL once-monthly injection for IV infusion.

Donanemab-AZBT is an IV infusion used to treat Alzheimer’s disease.

Donanemab-AZBT is targets beta-amyloid, a toxic protein that builds up in the brains of people with Alzheimer’s and forms plaques that can disrupt brain signaling. Donanemab-AZBT helps clear these plaques, which can help improve memory and thinking.

The recommended dosage of Donanemab-AZBT is 700 mg given as an IV infusion over 30 minutes every four weeks for the first three doses, followed by 1400 mg every four weeks. Your dose may be adjusted based on how well it works to remove plaque build-up.

Donanemab-AZBT is a safe and effective treatment when used for FDA approved indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not take Kinsula if you are allergic to Donanemab-AZBT or to any of the inactive ingredients in the product.

Common side effects of Donanemab-AZBT: Headache

Serious side effects are rare with Donanemab-AZBT. Contact your healthcare provider immediately if you experience any of the following: Allergic reactions or angioedema: skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing Worsening confusion, dizziness, change in vision, nausea, seizures Infusion reactions: chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded

There are no drug interactions listed for Donanemab-AZBT.

Various FDA-approved generic manufacturers

It is not known whether Donanemab-AZBT will harm your unborn baby. Talk with your healthcare provider about the risks of taking this medication if you are pregnant or plan on becoming pregnant.

• Kisunla